![]() |
|
|
|||||||
|
|
LinkBack | Thread Tools | Display Modes |
|
|||
|
Æterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today reported financial and operating results as at and for the fourth quarter and the full year ended December 31, 2009.
|
| Thread Tools | |
| Display Modes | |
|
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Aeterna Zentaris Reports Second Quarter 2010 Financial and Operating Results | cancerfr | Neuroblastoma | 0 | 08-13-2010 03:59 AM |
| Æterna Zentaris announces 2009 financial and operating results (News-Medical-Net) | cancerfr | Adrenocortical Carcinoma | 0 | 03-24-2010 03:38 PM |
| Æterna Zentaris announces 2009 financial and operating results (News-Medical-Net) | cancerfr | Bladder Cancer | 0 | 03-24-2010 03:38 PM |
| Æterna Zentaris Reports Fourth Quarter and Full-Year 2009 Financial and Operating Res | cancerfr | Bladder Cancer | 0 | 03-24-2010 03:38 PM |
| MDRNA, Inc. Announces Fourth Quarter and Full Year 2009 Financial Results (Marketwire | cancerfr | Adrenocortical Carcinoma | 0 | 03-23-2010 08:16 PM |